Year: 2024
Type: article
Study design: Case Report
Abstract: Rheumatoid arthritis (RA) can affect the elderly, posing distinct management and therapeutic issues. Polypharmacy is a significant concern, with a 36.4% prevalence among individuals aged 75 to 84 years. Older people are more susceptible to adverse effects due to various comorbidities and pharmacokinetic changes in metabolism and excretion. We provide a case of successfully treating late-onset RA (LORA) with baricitinib, emphasizing the importance of tailoring treatment to unique clinical conditions. We also discuss senile RA, biologics, and targeted therapies.
Source: Anti-Aging Eastern Europe
Authors: Tatjana Zekić, Nadica Laktašić Žerjavić
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4405863588